Clinical Trial Update: Evaluation of Effectiveness and Safety of Evolut R Valve In Patients With Pure Aortic Regurgitation [NA]

View source ↗

Summary

Clinical trial evaluating the Evolut R Valve for pure aortic regurgitation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Regurgitation

Drugs mentioned

• Evolut R Valve (transcatheter aortic valve replacement device)

Snippet

Sponsor: Seung-Jung Park | Conditions: Aortic Valve, Aortic Valve Insufficiency | NA | Status: TERMINATED